Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q4	-- / 8.828B	--
Feb 5, 2025	2025/Q3	-- / 8.328B	--
Nov 6, 2024	2025/Q2	6.959B / 6.284B	--
Aug 6, 2024	2025/Q1	5.550B / 6.346B	--
May 8, 2024	2024/Q4	8.466B / 8.205B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q4-- / 8.828B--

Feb 5, 20252025/Q3-- / 8.328B--

Nov 6, 20242025/Q26.959B / 6.284B--

Aug 6, 20242025/Q15.550B / 6.346B--

May 8, 20242024/Q48.466B / 8.205B--

Unlock Free Earnings Estimates

Open Account

Shin Nippon Biomedical Laboratories: Confirmatory letter.

Nov 5 22:17 ET

Shin Nippon Biomedical Laboratories: Interim report - 52nd term (2024/04/01 - 2025/03/31)

Nov 5 22:11 ET

Shin Nippon Biomedical Laboratories: Presentation of financial results for the first half of the fiscal year ending March 31, 2025

Nov 5 21:30 ET

Shin Nippon Biomedical Laboratories: Summary of Financial Results for the 2nd Quarter Ending March 31, 2025 [Japanese GAAP] (Consolidated)

Nov 5 21:30 ET

Symbol Price % Chg

See the daily top gainer.

Analysis

Updated: Dec 21, 2024

Buy

No Data